| Abstrakt: |
Extending biennial mammography screening for breast cancer from 75 to 80 years of age appears to be cost effective in the US, but gains few additional days of life, according to findings of a study published in the I Annals of Internal Medicine i . "Although annual mammography is not cost-effective, offering biennial screening mammography to women up to age 80 years seems to be cost-effective, especially for women with little or no comorbidity", the authors concluded. [Extracted from the article] |
Full text from SpringerLink